Author:
Eckermann Simon,Pekarsky Brita
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference28 articles.
1. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2005.
2. Barrett A, Riques T, Small M, Smith R. How much will Herceptin really cost? BMJ. 2006;333:1118–20.
3. Culyer AJ, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M, Brazier J. Searching for a threshold not setting one: the role of the National Institute for Health and Clinical Excellence. J Health Ser Res Policy. 2007;12(1):56–8.
4. McCabe C, Claxton K, Culyer AJ. The NICE cost effectiveness threshold: what it is and what that means. Pharmacoeconomics. 2008;26(9):733–44.
5. Claxton K, Briggs A, Buxton M, McCabe C, Culyer A, Walker S, Sculpher M. Value based pricing for NHS drugs: an opportunity not to be missed? BMJ. 2008;336:251–4.
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献